Two decades of clinical experience with the immunomodulatory treatment of multiple sclerosis points to distinct immunological pathways that drive disease relapses and progression. Although the ...
AAN: Drug Reduces Brain Lesions in Multiple Sclerosis Month of birth affects the risk of multiple sclerosis (MS). (HealthDay News) – Month of birth affects the risk of multiple sclerosis (MS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback